NVTA - Invitae Corp Stock Price, Fair Value and News

0USD0Market Closed

NVTA Stock Price

View Fullscreen

NVTA RSI Chart

NVTA Valuation

EV/EBITDA

-0.77

NVTA Price/Sales (Trailing)

NVTA Profitability

Operating Margin

27.13%

EBT Margin

-301.93%

Return on Equity

-5.5M%

Return on Assets

-269.22%

NVTA Fundamentals

NVTA Revenue

Revenue (TTM)

481.6M

Rev. Growth (Yr)

-9.21%

Rev. Growth (Qtr)

0.59%

NVTA Earnings

Earnings (TTM)

-1.4B

Earnings Growth (Yr)

-212.83%

Earnings Growth (Qtr)

-356.2%

Breaking Down NVTA Revenue

Last 30 days

-50%

Last 90 days

-98%

Trailing 12 Months

-99.3%

How does NVTA drawdown profile look like?

NVTA Financial Health

Current Ratio

2.39

Debt/Equity

43.4K

Debt/Cashflow

-0.21

NVTA Investor Care

Shares Dilution (1Y)

17.95%

Diluted EPS (TTM)

-6.24

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	510.0M	493.9M	481.6M	0
2022	480.5M	500.8M	520.0M	516.3M
2021	319.0M	389.1M	434.8M	460.4M
2020	240.5M	233.2M	245.5M	279.6M
2019	160.6M	176.8M	195.9M	216.8M
2018	85.6M	108.5M	127.7M	147.7M
2017	31.4M	40.2M	52.1M	68.2M
2016	11.1M	14.9M	19.0M	25.0M
2015	2.7M	4.2M	6.1M	8.4M
2014	512.0K	876.0K	1.2M	1.6M
2013	0	0	0	148.0K

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Invitae Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Dec 20, 2023	brida thomas	sold (taxes)	-11,277	0.648	-17,404	see remarks
Dec 20, 2023	nussbaum robert l	sold (taxes)	-11,277	0.648	-17,404	chief medical officer
Nov 13, 2023	sholehvar david	acquired	-	-	850,000	chief operating officer
Oct 18, 2023	brida thomas	acquired	-	-	229,500	see remarks
Oct 02, 2023	schrank ana j.	acquired	-	-	850,000	chief financial officer
Sep 23, 2023	guigley robert m.	acquired	-	-	850,000	chief commercial officer
Jun 13, 2023	brida thomas	sold	-9,747	1.377	-7,079	see remarks
Jun 13, 2023	nussbaum robert l	sold	-9,757	1.377	-7,086	chief medical officer
May 16, 2023	werner robert f.	sold	-25,855	1.1993	-21,559	chief accounting officer
May 16, 2023	knight kenneth d.	sold	-54,486	1.1993	-45,432	chief executive officer

Which funds bought or sold NVTA recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 16, 2024	TOTH FINANCIAL ADVISORY CORP	sold off	-100	-242	-	-%
Apr 16, 2024	Register Financial Advisors LLC	new	-	2.00	2.00	-%
Apr 15, 2024	Sunbelt Securities, Inc.	unchanged	-	-67.00	1.00	-%
Apr 15, 2024	WEALTH ENHANCEMENT ADVISORY SERVICES, LLC	sold off	-100	-9,978	-	-%
Apr 15, 2024	Concurrent Investment Advisors, LLC	new	-	6,828	6,828	-%
Apr 15, 2024	Security National Bank	sold off	-100	-66.00	-	-%
Apr 15, 2024	WEST PACES ADVISORS INC.	unchanged	-	-9.00	-	-%
Apr 12, 2024	Divergent Planning, LLC	sold off	-100	-70,709	-	-%
Apr 12, 2024	BOURNE LENT ASSET MANAGEMENT INC	sold off	-100	-360,159	-	-%
Apr 12, 2024	AdvisorNet Financial, Inc	added	150	-11,986	550	-%

Are Funds Buying or Selling NVTA?

Are funds buying NVTA calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NVTA

No. of Funds

Unveiling Invitae Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	nikko asset management americas, inc.	5.85%	16,764,480	SC 13G/A
Feb 13, 2024	vanguard group inc	5.12%	14,660,153	SC 13G/A
Feb 05, 2024	sumitomo mitsui trust holdings, inc.	5.85%	16,764,480	SC 13G/A
Jan 29, 2024	ark investment management llc	11.36%	32,550,683	SC 13G/A
Jan 29, 2024	blackrock inc.	6.7%	19,258,772	SC 13G/A
Aug 30, 2023	flynn james e	4.9%	93,062,106	SC 13G
Feb 14, 2023	casdin capital, llc	3.72%	9,038,388	SC 13G/A
Feb 10, 2023	ark investment management llc	11.15%	27,072,844	SC 13G/A
Feb 10, 2023	nikko asset management americas, inc.	7.10%	17,256,161	SC 13G/A
Feb 09, 2023	vanguard group inc	9.30%	22,587,955	SC 13G/A

Recent SEC filings of Invitae Corp

View All Filings

Date Filed	Form Type	Document
Apr 04, 2024	8-K	Current Report
Mar 06, 2024	8-K	Current Report
Feb 21, 2024	25-NSE	25-NSE
Feb 14, 2024	8-K	Current Report
Feb 13, 2024	SC 13G/A	Major Ownership Report
Feb 13, 2024	SC 13G/A	Major Ownership Report
Feb 06, 2024	8-K	Current Report
Feb 05, 2024	SC 13G/A	Major Ownership Report
Jan 29, 2024	SC 13G/A	Major Ownership Report
Jan 29, 2024	SC 13G/A	Major Ownership Report

Peers (Alternatives to Invitae Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
DHR	174.9B	23.9B	-4.84%	-6.57%	36.87	7.32	-10.33%	-33.23%
IDXX	39.7B	3.7B	-9.80%	-0.88%	47	10.85	8.72%	24.44%
A	38.8B	6.7B	-7.93%	-3.24%	31.4	5.76	-2.81%	-6.58%
DGX	13.9B	9.3B	-0.92%	-10.65%	16.33	1.51	-6.38%	-9.73%
CRL	11.7B	4.1B	-12.26%	11.63%	24.62	2.83	3.86%	-2.39%
EXAS	11.5B	2.5B	7.41%	-3.33%	-56.42	4.61	19.93%	67.26%
MEDP	11.5B	1.9B	-2.07%	99.71%	40.69	6.1	29.17%	15.26%
NTRA	10.5B	1.1B	0.24%	79.92%	-24.22	9.73	31.99%	20.63%
MID-CAP
NEOG	2.6B	929.2M	-19.44%	-25.48%	1.7K	2.83	28.93%	111.61%
GH	2.0B	563.9M	-6.02%	-33.20%	-4.23	3.6	25.45%	26.76%
SMALL-CAP
CDNA	428.7M	280.3M	-16.28%	-8.71%	-2.25	1.53	-12.89%	-148.37%
ACRS	87.9M	31.2M	6.96%	-86.73%	-0.99	2.81	5.03%	-1.81%
AWH	43.1M	9.2M	-4.38%	-37.12%	-2.58	4.71	11.85%	44.12%
APDN	5.6M	9.0M	-25.00%	-68.27%	-0.78	0.62	-53.31%	2.21%
BIOC	183.8K	25.9M	-50.00%	-94.83%	-0.01	0.01	-57.78%	-93.11%

Invitae Corp News

Latest updates

Invitae Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Revenue	0.6%	121,241,000	120,532,000	117,356,000	122,454,000	133,536,000	136,622,000	123,691,000	126,121,000	114,395,000	116,312,000	103,621,000	100,431,000	68,728,000	46,191,000	64,248,000	66,285,000	56,511,000	53,475,000	40,553,000	45,356,000	37,366,000
Cost Of Revenue	-6.0%	82,186,000	87,474,000	88,442,000	92,844,000	116,956,000	110,340,000	97,116,000	96,106,000	87,741,000	89,331,000	75,491,000	68,258,000	46,643,000	42,952,000	40,422,000	36,723,000	32,120,000	28,006,000	21,254,000	21,141,000	20,441,000
Costs and Expenses	217.4%	1,101,429,000	346,994,000	292,727,000	217,349,000	423,487,000	2,656,953,000	336,924,000	340,695,000	307,707,000	-12,297,000	215,985,000	-	-	-	-	-	-	-	-	71,260,000	67,476,000
S&GA Expenses	-15.1%	37,999,000	44,732,000	44,510,000	46,795,000	49,193,000	62,749,000	60,144,000	62,205,000	55,501,000	56,964,000	51,240,000	48,877,000	37,800,000	39,520,000	42,120,000	34,575,000	32,690,000	30,779,000	24,193,000	19,206,000	17,591,000
R&D Expenses	-8.6%	58,336,000	63,824,000	61,978,000	71,529,000	87,177,000	115,146,000	128,236,000	131,764,000	97,511,000	106,454,000	80,358,000	72,172,000	37,802,000	74,963,000	55,668,000	51,279,000	46,951,000	25,302,000	17,994,000	16,570,000	15,776,000
EBITDA Margin	-113.6%	-2.62	-1.22	-5.73	-5.72	-5.91	-5.98	-0.77	-0.62	-0.98	-0.89	-2.04	-2.31	-	-	-	-	-	-	-	-	-
Interest Expenses	-2.8%	5,850,000	6,020,000	11,496,000	14,598,000	14,145,000	14,019,000	13,985,000	14,031,000	14,069,000	13,407,000	8,393,000	12,522,000	6,308,000	5,485,000	5,451,000	5,350,000	2,833,000	2,121,000	2,108,000	2,103,000	1,844,000
Income Taxes	-567.9%	-6,171,000	-924,000	-960,000	-5,334,500	-1,068,000	-3,600,000	-34,920,000	-7,649,000	-5,848,000	-16,560,000	-6,800,000	-109,500,000	-	-2,600,000	-	-	-8,700,000	-3,950,000	-	-2,800,000	-
Earnings Before Taxes	-357.1%	-948,278,000	-207,435,000	-193,143,000	-105,170,000	-302,224,000	-2,527,024,000	-216,779,000	-212,773,000	-204,024,000	117,226,000	-116,292,000	-343,838,000	-102,902,000	-169,003,000	-98,527,000	-82,705,000	-87,407,000	-52,626,000	-	-32,641,000	-31,723,000
EBT Margin	-84.6%	-3.02	-1.64	-6.13	-6.10	-6.27	-6.31	-1.07	-0.90	-1.26	-1.15	-2.29	-2.55	-	-	-	-	-	-	-	-	-
Net Income	-356.2%	-942,107,000	-206,511,000	-192,183,000	-99,817,000	-301,156,000	-2,523,461,000	-181,859,000	-205,124,000	-198,176,000	133,786,000	-109,492,000	-234,338,000	-102,902,000	-166,403,000	-98,527,000	-76,905,000	-78,707,000	-48,676,000	-37,677,000	-29,841,000	-31,723,000
Net Income Margin	-84.8%	-2.99	-1.62	-6.11	-6.02	-6.18	-6.21	-0.94	-0.82	-0.94	-0.80	-1.92	-2.15	-	-	-	-	-	-	-	-	-
Free Cashflow	-22.2%	-68,825,000	-56,322,000	-35,722,000	-86,990,000	-140,117,000	-150,811,000	-168,391,000	-195,090,000	-180,431,000	-143,048,000	-95,951,000	-122,454,000	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Assets	-64.9%	535	1,523	1,692	1,954	2,026	2,291	4,768	4,920	5,071	4,995	3,873	3,430	913	970	791	782	790	503	476	283	284
Current Assets	-16.1%	378	451	504	693	730	894	1,031	1,179	1,366	1,644	780	454	415	471	357	442	509	288	321	165	167
Cash Equivalents	-29.1%	158	223	161	257	217	304	325	934	922	1,108	204	131	113	175	97.00	158	473	253	258	118	106
Inventory	3.9%	22.00	21.00	19.00	30.00	30.00	49.00	43.00	34.00	31.00	30.00	31.00	32.00	-	-	-	7.00	-	-	-	-	-
Net PPE	-28.9%	65.00	92.00	95.00	109	114	133	130	115	101	83.00	73.00	66.00	46.00	43.00	41.00	38.00	32.00	29.00	26.00	28.00	29.00
Goodwill	-	-	-	-	-	-	-	2,283	2,283	222	2,061	1,926	1,864	211	211	51.00	127	100	26.00	50.00	50.00	47.00
Liabilities	-6.1%	1,619	1,724	1,728	1,852	1,867	1,905	1,924	1,941	1,964	2,341	1,497	1,454	497	506	465	402	387	161	160	121	105
Current Liabilities	4.2%	158	152	190	108	113	139	168	144	156	134	146	122	101	127	121	82.00	69.00	40.00	42.00	36.00	43.00
Long Term Debt	-3.7%	1,128	1,171	1,169	1,471	1,469	1,467	1,466	1,464	1,462	1,461	343	284	280	276	272	269	-	75.00	75.00	74.00	50.00
LT Debt, Non Current	-3.7%	1,128	1,171	1,169	1,471	1,469	1,467	1,466	1,464	1,462	1,461	343	284	280	276	272	269	-	75.00	75.00	74.00	50.00
Shareholder's Equity	-	-	-	0.00	102	159	386	2,844	4,701	3,107	2,654	2,376	1,976	417	0.00	0.00	380	404	945	0.00	0.00	179
Retained Earnings	-18.0%	-6,169	-5,227	-5,021	-4,800	-4,729	-4,428	-1,904	-1,722	-1,517	-1,319	-1,453	-1,360	-1,126	-1,023	-857	-758	-681	-603	-554	-516	-486
Additional Paid-In Capital	0.9%	5,061	5,018	4,985	4,931	4,889	4,815	4,749	4,701	4,624	3,973	3,830	3,337	1,543	1,487	1,182	1,138	1,086	945	871	679	666
Shares Outstanding	-0.2%	263	264	250	246	233	232	228	228	206	204	194	135	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	-	570	-	-	-	6,800	-	-	-	4,000	-	-	-	2,100	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Cashflow From Operations	-21.8%	-66,897	-54,905	-34,398	-82,066	-128,702	-134,689	-147,543	-175,903	-165,052	-129,325	-89,520	-113,580	-62,166	-60,394	-62,360	-47,266	-36,696	-32,725	-28,366	-15,473	-18,080
Share Based Compensation	-14.4%	25,997	30,364	29,193	34,990	60,413	57,079	46,822	48,307	25,431	47,562	58,775	56,418	21,205	51,846	29,278	28,122	28,286	14,317	5,223	10,798	-
Cashflow From Investing	-95.6%	5,117	116,064	73,878	121,891	43,797	108,965	-449,456	170,503	-20,324	-80,701	-273,558	-312,292	-5,674	-83,417	800	-270,698	-17,200	25,133	-17,545	11,184	6,530
Cashflow From Financing	-486.0%	-3,381	876	-135,768	599	-1,691	3,770	-920	7,031	-735	1,123,553	436,091	444,233	6,415	221,794	551	2,341	273,848	2,462	186,120	16,028	64,100

NVTA Income Statement

2023-09-30

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenue:
Total revenue	$ 121,241	$ 133,536	$ 359,129	$ 393,849
Operating expenses:
Cost of revenue	82,186	116,956	258,102	324,412
Research and development	58,336	87,177	184,138	330,559
Selling and marketing	37,999	49,193	127,241	172,086
General and administrative	45,619	44,939	160,826	147,221
Goodwill and IPR&D impairment	0	0	0	2,313,047
Restructuring, impairment and other costs	877,289	125,222	1,010,843	130,039
Total operating expenses	1,101,429	423,487	1,741,150	3,417,364
Loss from operations	(980,188)	(289,951)	(1,382,021)	(3,023,515)
Other income (expense), net:
Gain (loss) on extinguishment of debt, net	229	0	(10,593)	0
Debt issuance costs	(845)	0	(20,704)	0
Change in fair value of convertible senior secured notes	33,463	0	72,386	0
Change in fair value of acquisition-related liabilities	70	(527)	337	15,666
Other income, net	4,843	2,399	15,105	3,971
Total other income, net	37,760	1,872	56,531	19,637
Interest expense	(5,850)	(14,145)	(23,366)	(42,149)
Net loss before taxes	(948,278)	(302,224)	(1,348,856)	(3,046,027)
Income tax benefit	6,171	1,068	8,055	39,551
Net loss	$ (942,107)	$ (301,156)	$ (1,340,801)	$ (3,006,476)
Net (loss) income per share, basic (in dollars per share)	$ (3.42)	$ (1.27)	$ (5.09)	$ (12.91)
Net (loss) income per share, diluted (in dollars per share)	$ (3.42)	$ (1.27)	$ (5.09)	$ (12.91)
Shares used in computing net loss per share, basic	275,604	237,974	263,210	232,889
Shares used in computing net loss per share, diluted	275,604	237,974	263,210	232,889
Test revenue
Revenue:
Total revenue	$ 117,561	$ 128,839	$ 346,127	$ 381,518
Other revenue
Revenue:
Total revenue	$ 3,680	$ 4,697	$ 13,002	$ 12,331

NVTA Balance Sheet

2023-09-30

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 158,007	$ 257,489
Marketable securities	96,566	289,611
Accounts receivable	82,507	96,148
Inventory	21,627	30,386
Prepaid expenses and other current assets	19,692	19,496
Total current assets	378,399	693,130
Property and equipment, net	65,446	108,723
Operating lease assets	61,639	106,563
Restricted cash	10,100	10,030
Intangible assets, net	0	1,012,549
Other assets	19,531	23,121
Total assets	535,115	1,954,116
Current liabilities:
Accounts payable	25,185	13,984
Accrued liabilities	84,729	74,388
Operating lease obligations	17,650	14,600
Finance lease obligations	3,948	5,121
Total current liabilities	158,419	108,093
Operating lease obligations, net of current portion	134,945	134,386
Finance lease obligations, net of current portion	855	3,780
Convertible senior notes, net current portion	26,907	0
Debt	0	122,333
Convertible senior notes, net	1,127,830	1,470,783
Convertible senior secured notes (at fair value)	196,244	0
Deferred tax liability	0	8,130
Other long-term liabilities	226	4,775
Total liabilities	1,618,519	1,852,280
Commitments and contingencies
Stockholders’ (deficit) equity:
Common stock	29	25
Accumulated other comprehensive income (loss)	25,378	(80)
Additional paid-in capital	5,061,131	4,931,032
Accumulated deficit	(6,169,942)	(4,829,141)
Total stockholders’ (deficit) equity	(1,083,404)	101,836
Total liabilities and stockholders’ (deficit) equity	$ 535,115	$ 1,954,116

About Invitae Corp

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

CEO	Mr. Kenneth D. Knight
WEBSITE	invitae.com
INDUSTRY	Diagnostics & Research
EMPLOYEES	1700

Invitae Corp Frequently Asked Questions

What is the ticker symbol for Invitae Corp? What does NVTA stand for in stocks?

NVTA is the stock ticker symbol of Invitae Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Invitae Corp (NVTA)?

As of Wed Apr 17 2024, market cap of Invitae Corp is 0. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NVTA stock?

You can check NVTA's fair value in chart for subscribers.

What is the fair value of NVTA stock?

You can check NVTA's fair value in chart for subscribers. The fair value of Invitae Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Invitae Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NVTA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Invitae Corp a good stock to buy?

The fair value guage provides a quick view whether NVTA is over valued or under valued. Whether Invitae Corp is cheap or expensive depends on the assumptions which impact Invitae Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NVTA.

What is Invitae Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Apr 17 2024, NVTA's PE ratio (Price to Earnings) is 0 and Price to Sales (PS) ratio is 0. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NVTA PE ratio will change depending on the future growth rate expectations of investors.